富士製薬工業(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4554/E00975 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2023/04/21 | 日証協 | 40,508株 | -11.38% | 12,712株 | -30.18% | 445,314株 | -0.63% | 79,870株 | -1.78% |
2023/04/14 | 日証協 | 45,708株 | -1.06% | 18,208株 | -63.8% | 448,144株 | -2.5% | 81,320株 | -55.32% |
2023/04/07 | 日証協 | 46,200株 | +63.83% | 50,300株 | +222.44% | 459,648株 | +86.91% | 182,010株 | -52.27% |
2023/03/31 | 日証協 | 28,200株 | -61.41% | 15,600株 | +22.67% | 245,918株 | -39.31% | 381,331株 | +293% |
2023/03/24 | 日証協 | 73,077株 | +0.83% | 12,717株 | -31.17% | 405,184株 | +19.28% | 97,030株 | +13.2% |
2023/03/17 | 日証協 | 72,477株 | -61.16% | 18,477株 | +47.82% | 339,684株 | -0.17% | 85,715株 | +234.37% |
2023/03/10 | 日証協 | 186,600株 | -42.5% | 12,500株 | -30.56% | 340,265株 | -19.38% | 25,635株 | -40.76% |
2023/03/03 | 日証協 | 324,547株 | -3.36% | 18,000株 | +36.36% | 422,065株 | +1.36% | 43,271株 | +323.52% |
2023/02/24 | 日証協 | 335,847株 | +1.57% | 13,200株 | +127.59% | 416,422株 | -1.23% | 10,217株 | -42.37% |
2023/02/17 | 日証協 | 330,647株 | +1.63% | 5,800株 | -50% | 421,622株 | +1.33% | 17,730株 | +25.74% |
2023/02/10 | 日証協 | 325,345株 | +0.34% | 11,600株 | -83.07% | 416,097株 | -0.79% | 14,101株 | -83.11% |
2023/02/03 | 日証協 | 324,245株 | -0.57% | 68,500株 | +9999.99% | 419,396株 | -1.94% | 83,490株 | +695.22% |
2023/01/27 | 日証協 | 326,100株 | -2.92% | 400株 | -98.07% | 427,696株 | -2.97% | 10,499株 | -53.57% |
2023/01/20 | 日証協 | 335,900株 | +11.26% | 20,700株 | +475.32% | 440,795株 | +3.5% | 22,612株 | -0.07% |
2023/01/13 | 日証協 | 301,900株 | +1.1% | 3,598株 | -32.15% | 425,884株 | +3.88% | 22,627株 | -5.89% |
2023/01/06 | 日証協 | 298,602株 | -2.53% | 5,303株 | -97.21% | 409,974株 | +0.57% | 24,044株 | -67.43% |
2022/12/30 | 日証協 | 306,355株 | +67.27% | 190,200株 | +137.75% | 407,653株 | +0.05% | 73,815株 | -23.7% |
2022/12/23 | 日証協 | 183,155株 | +0.34% | 80,000株 | +1233.33% | 407,447株 | +0.47% | 96,739株 | +315.46% |
2022/12/16 | 日証協 | 182,530株 | 0% | 6,000株 | +475.82% | 405,530株 | +1.61% | 23,285株 | -34.65% |
※株式分割は考慮していませんのでご注意ください。
Page Top